降钙素原(PCT)急诊临床应用的专家共识(5)
[15]Menéndez R， Cavalcanti M， Reyes S， et al. Markers of treatment failure in hospitalised community acquired pneumonia[J]. Thorax， 2008，63(5)：447—452.
[16]Schuetz P， Christ—Crain M， Wolbers M， et al. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections： a prospective， multicenter， randomized controlled trial[J]. BMC Health Serv Res， 2007，7：102. [17]Boussekey N， Leroy O， Alfandari S， et al. Procalcitonin kinetics in the prognosis of severe community—acquired pneumonia[J]. Intensive Care Med， 2006，32(3)：469—472.
, 百拇医药
[18]Christ—Crain M， Opal SM. Clinical review： the role of biomarkers in the diagnosis and management of community—acquired pneumonia[J]. Crit Care， 2010，14(1)：203.
[19]Mueller C， Christ—Crain M， Müller B. What cardiologists do need to know about procalcitonin[J]. Clin Lab， 2005，51(1/2)：1—4.
[20]Gendrel D， Raymond J， Assicot M， et al. Measurement of pro—calcitonin levels in children with bacterial or viral meningitis[J]. Clin Infect Dis， 1997，24(6)：1240—1242.
, 百拇医药
[21]BalcI C， Sungurtekin H， Gürses E， et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit[J]. Crit Care， 2003，7(1)：85—90.
[22]Reith HB， Mittelk?tter U， Wagner R， et al. Procalcitonin (PCT) in patients with abdominal sepsis[J]. Intensive Care Med， 2000，26 Suppl 2：S165—169.
[23]Marc E， Ménager C， Moulin F， et al. Procalcitonin and viral meningitis： reduction of unnecessary antibiotics by measurement during an outbreak[J]. Arch Pediatr， 2002，9(4)：358—364.
, 百拇医药
[24]Moulin F， Raymond J， Lorrot M，et al. Procalcitonin in children admitted to hospital with community acquired pneumonia[J]. Arch Dis Child， 2001，84(4)：332—336.
[25]Boutoille D， Struillou L， El Kouri D， et al. Meningitis with direct negative bacteriological examination. Prospective assessment of a decision making tree[J]. Presse Med， 2004，33(4)：235—240.
[26]Toikka P， Irjala K， Juvén T， et al. Serum procalcitonin， C—reactive protein and interleukin—6 for distinguishing bacterial and viral pneumonia in children[J]. Pediatr Infect Dis J， 2000，19(7)：598—602.
, 百拇医药
[27]Resch B， Gusenleitner W， Müller W. Procalcitonin， interleukin—6， C—reactive protein and leukocyte counts in infants with bronchiolitis[J]. Pediatr Infect Dis J， 2003，22(5)：475—476.
[28]Chua AP， Lee KH. Procalcitonin in severe acute respiratory syndrome (SARS) [J]. J Infect， 2004，48(4)：303—306.
[29]Korppi M， Remes S， Heiskanen—Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children： a negative result in primary healthcare settings[J]. Pediatr Pulmonol， 2003，35(1)：56—61.
, 百拇医药(降钙素原急诊临床应用专家共识组)
[16]Schuetz P， Christ—Crain M， Wolbers M， et al. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections： a prospective， multicenter， randomized controlled trial[J]. BMC Health Serv Res， 2007，7：102. [17]Boussekey N， Leroy O， Alfandari S， et al. Procalcitonin kinetics in the prognosis of severe community—acquired pneumonia[J]. Intensive Care Med， 2006，32(3)：469—472.
, 百拇医药
[18]Christ—Crain M， Opal SM. Clinical review： the role of biomarkers in the diagnosis and management of community—acquired pneumonia[J]. Crit Care， 2010，14(1)：203.
[19]Mueller C， Christ—Crain M， Müller B. What cardiologists do need to know about procalcitonin[J]. Clin Lab， 2005，51(1/2)：1—4.
[20]Gendrel D， Raymond J， Assicot M， et al. Measurement of pro—calcitonin levels in children with bacterial or viral meningitis[J]. Clin Infect Dis， 1997，24(6)：1240—1242.
, 百拇医药
[21]BalcI C， Sungurtekin H， Gürses E， et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit[J]. Crit Care， 2003，7(1)：85—90.
[22]Reith HB， Mittelk?tter U， Wagner R， et al. Procalcitonin (PCT) in patients with abdominal sepsis[J]. Intensive Care Med， 2000，26 Suppl 2：S165—169.
[23]Marc E， Ménager C， Moulin F， et al. Procalcitonin and viral meningitis： reduction of unnecessary antibiotics by measurement during an outbreak[J]. Arch Pediatr， 2002，9(4)：358—364.
, 百拇医药
[24]Moulin F， Raymond J， Lorrot M，et al. Procalcitonin in children admitted to hospital with community acquired pneumonia[J]. Arch Dis Child， 2001，84(4)：332—336.
[25]Boutoille D， Struillou L， El Kouri D， et al. Meningitis with direct negative bacteriological examination. Prospective assessment of a decision making tree[J]. Presse Med， 2004，33(4)：235—240.
[26]Toikka P， Irjala K， Juvén T， et al. Serum procalcitonin， C—reactive protein and interleukin—6 for distinguishing bacterial and viral pneumonia in children[J]. Pediatr Infect Dis J， 2000，19(7)：598—602.
, 百拇医药
[27]Resch B， Gusenleitner W， Müller W. Procalcitonin， interleukin—6， C—reactive protein and leukocyte counts in infants with bronchiolitis[J]. Pediatr Infect Dis J， 2003，22(5)：475—476.
[28]Chua AP， Lee KH. Procalcitonin in severe acute respiratory syndrome (SARS) [J]. J Infect， 2004，48(4)：303—306.
[29]Korppi M， Remes S， Heiskanen—Kosma T. Serum procalcitonin concentrations in bacterial pneumonia in children： a negative result in primary healthcare settings[J]. Pediatr Pulmonol， 2003，35(1)：56—61.
, 百拇医药(降钙素原急诊临床应用专家共识组)